Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2036

Annual patent cliff calendar for 2036 — US pharmaceutical patents by expiration date.

Patents
1,428

Quick answer

1,428 indexed pharmaceutical patents have expiration dates in 2036. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 9346867

    Cancer-related glycopeptide epitopes, antibodies and methods of use

    SUMITOMO BAKELITE CO., LTD. · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9346865

    Antimicrobial peptides and methods of use

    The Regents of the University of Colorado, a Body Corporate · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9346917

    Method involving 1-benzotriazolyl carbonate esters of poly(ethylene glycol)

    Nektar Therapeutics · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9346880

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9347054

    Polymer factor IX moiety conjugates

    Nektar Therapeutics · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9346859

    Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9347062

    Interfering RNA delivery system and uses thereof

    Arrowhead Research Corporation · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9346866

    Inhibition of tace activity with cyclic peptides

    The Regents of the University of California · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9347063

    Oligonucleotide analog and method for treating flavivirus infections

    Sarepta Therapeutics, Inc. · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9347143

    Membrane template synthesis of microtube engines

    The Regents of the University of California · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9346746

    R(+)-N-formyl-propargyl-aminoindan

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9345780

    Site specific delivery of nucleic acids by combining targeting ligands with endosomolytic components

    Tekmira Pharmaceuticals Corporation · Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. PH 12016500580

    CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER

    OXFORD BIOTHERAPEUTICS LTD [GB] · Granted Mon May 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Sun May 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9351970

    Anti-viral pyrimidine nucleoside analogues

    University College Cardiff Consultants Limited · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9353176

    Method of treating osteoarthritis with an antibody to NGF

    REGENERON PHARMACEUTICALS, INC. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9353124

    Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9353075

    Disubstituted beta-lactones as inhibitors of N-acylethanolamine acid amidase (NAAA)

    The Regents of the University of California · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9352015

    Antimicrobial peptides

    The Regents of the University of Colorado, a Body Corporate · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9351960

    Agent for the treatment of viral hepatitis C

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9351954

    Multicyclic compounds and methods of use thereof

    PGI Drug Discovery LLC · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9351975

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9351962

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9351989

    Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections

    University College Cardiff Consultants Limited · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9351964

    Methods for treating cancer and non-neoplastic conditions

    PTC THERAPEUTICS, INC. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9351968

    Methods of treating developmental disorders using pipradrol

    OVID THERAPEUTICS INC. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9351997

    Method of treating cancer

    Intensity Therapeutics, Inc. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9351984

    Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity

    The Board of Regents of the University of Texas System · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9352048

    Carbohydrate conjugates as delivery agents for oligonucleotides

    Alnylam Pharmaceuticals, Inc. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9352032

    Live attenuated antigenically marked classical swine fever vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9352011

    Method and composition for synchronizing time of insemination

    JBS United Animal Health II LLC · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9352019

    Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

    University of Connecticut Health Center · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9351490

    Selectively targeted antimicrobial peptides and the use thereof

    The Regents of the University of California · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9352027

    Albumin-free factor VIII formulations

    UNIVERSITY OF CONNECTICUT · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9353069

    Super-oxide dismutase mimetics

    Galera Labs, LLC · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9353106

    Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

    Theravance Biopharma R&D IP, LLC · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9353094

    Substituted quinoxalines as kinase inhibitors

    The Board of Regents of the University of Texas System · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9353107

    3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives as kinase inhibitors

    Aurigene Discovery Technologies Limited · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9353108

    Tetrahydronaphthyridine somatostatin receptor 5 antagonists

    Takeda Pharmaceutical Company Limited · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9353175

    Use of antagonists targeting metallothionein to treat intestinal inflammation

    UNIVERSITY OF CONNECTICUT · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9353111

    Carboxamide compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9353126

    Substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9353163

    Apelin fusion proteins and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9353352

    Embryonic stem cell specific microRNAs promote induced pluripotency

    The Regents of the University of California · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9353240

    Elastomer formulations comprising discrete carbon nanotube fibers

    MOLECULAR REBAR DESIGN, LLC · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9353117

    Substituted pyrazolopyrimidines as glucocerebrosidase activators

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9353353

    Virus-like particles (VLPs) prepared from chikungunya virus structural proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9353178

    Stem cell factor inhibitor

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9353112

    Synthesis of polycyclic alkaloids

    Rigel Pharmaceuticals, Inc. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2036?

1,428 published patents in our USPTO index have expiration dates falling in calendar year 2036.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.